These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 28785427)

  • 1. Left Ventricular Assist Devices in the Management of Heart Failure.
    Y Birati E; Jessup M
    Card Fail Rev; 2015 Apr; 1(1):25-30. PubMed ID: 28785427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ethical challenges with the left ventricular assist device as a destination therapy.
    Rizzieri AG; Verheijde JL; Rady MY; McGregor JL
    Philos Ethics Humanit Med; 2008 Aug; 3():20. PubMed ID: 18694496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Left ventricular assist devices: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2004; 4(3):1-69. PubMed ID: 23074453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advanced heart failure treated with continuous-flow left ventricular assist device.
    Slaughter MS; Rogers JG; Milano CA; Russell SD; Conte JV; Feldman D; Sun B; Tatooles AJ; Delgado RM; Long JW; Wozniak TC; Ghumman W; Farrar DJ; Frazier OH;
    N Engl J Med; 2009 Dec; 361(23):2241-51. PubMed ID: 19920051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Derivation and Validation of a Novel Right-Sided Heart Failure Model After Implantation of Continuous Flow Left Ventricular Assist Devices: The EUROMACS (European Registry for Patients with Mechanical Circulatory Support) Right-Sided Heart Failure Risk Score.
    Soliman OII; Akin S; Muslem R; Boersma E; Manintveld OC; Krabatsch T; Gummert JF; de By TMMH; Bogers AJJC; Zijlstra F; Mohacsi P; Caliskan K;
    Circulation; 2018 Feb; 137(9):891-906. PubMed ID: 28847897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes after implantation of partial-support left ventricular assist devices in inotropic-dependent patients: Do we still need full-support assist devices?
    Sabashnikov A; Popov AF; Bowles CT; Mohite PN; Weymann A; Hards R; Hedger M; Wittwer T; Wippermann J; Wahlers T; Schoendube FA; Simon AR
    J Thorac Cardiovasc Surg; 2014 Sep; 148(3):1115-21; discussion 1021-2. PubMed ID: 25129605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiac extracorporeal life support: state of the art in 2007.
    Cooper DS; Jacobs JP; Moore L; Stock A; Gaynor JW; Chancy T; Parpard M; Griffin DA; Owens T; Checchia PA; Thiagarajan RR; Spray TL; Ravishankar C
    Cardiol Young; 2007 Sep; 17 Suppl 2():104-15. PubMed ID: 18039404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Durability of left ventricular assist devices: Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) 2006 to 2011.
    Holman WL; Naftel DC; Eckert CE; Kormos RL; Goldstein DJ; Kirklin JK
    J Thorac Cardiovasc Surg; 2013 Aug; 146(2):437-41.e1. PubMed ID: 23490245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ventricular assist device for end-stage adult congenital heart disease patients: Current status.
    Shinkawa T; Ichihara Y; Saito S; Ishido M; Inai K; Niinami H
    J Cardiol; 2023 Apr; 81(4):378-384. PubMed ID: 36152979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ventricular assist device: saving the failing heart.
    Kurien S; Gallagher C
    Prog Transplant; 2010 Jun; 20(2):134-41. PubMed ID: 20642171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of Safety and Effectiveness of the Extracorporeal Continuous-Flow Ventricular Assist Device (BR16010) Use as a Bridge-to-Decision Therapy for Severe Heart Failure or Refractory Cardiogenic Shock: Study Protocol for Single-Arm Non-randomized, Uncontrolled, and Investigator-Initiated Clinical Trial.
    Fukushima N; Tatsumi E; Seguchi O; Takewa Y; Hamasaki T; Onda K; Yamamoto H; Hayashi T; Fujita T; Kobayashi J
    Cardiovasc Drugs Ther; 2018 Aug; 32(4):373-379. PubMed ID: 29948739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of Hypertension in Patients With Ventricular Assist Devices: A Scientific Statement From the American Heart Association.
    Eisen HJ; Flack JM; Atluri P; Bansal N; Breathett K; Brown AL; Hankins SR; Khazanie P; Masri C; Pirlamarla P; Rowe T;
    Circ Heart Fail; 2022 May; 15(5):e000074. PubMed ID: 35430896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolution of Left Ventricular Assist Device Therapy for Advanced Heart Failure: A Review.
    Miller LW; Rogers JG
    JAMA Cardiol; 2018 Jul; 3(7):650-658. PubMed ID: 29710092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracorporeal membrane oxygenation versus counterpulsatile, pulsatile, and continuous left ventricular unloading for pediatric mechanical circulatory support.
    Bartoli CR; Koenig SC; Ionan C; Gillars KJ; Mitchell ME; Austin EH; Gray LA; Pantalos GM
    Pediatr Crit Care Med; 2013 Nov; 14(9):e424-37. PubMed ID: 24108116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virtual implantation and patient-specific simulation for optimization of outcomes in ventricular assist device recipients.
    Anselmi A; Collin S; Haigron P; Verhoye JP; Flecher E
    Med Hypotheses; 2016 Jun; 91():67-72. PubMed ID: 27142147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolated permanent right ventricular assist device implantation with the HeartWare continuous-flow ventricular assist device: first results from the European Registry for Patients with Mechanical Circulatory Support.
    Bernhardt AM; De By TM; Reichenspurner H; Deuse T
    Eur J Cardiothorac Surg; 2015 Jul; 48(1):158-62. PubMed ID: 25354745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Implications of Respiratory Failure in Patients Receiving Durable Left Ventricular Assist Devices for End-Stage Heart Failure.
    Miller PE; Caraballo C; Ravindra NG; Mezzacappa C; McCullough M; Gruen J; Levin A; Reinhardt S; Ali A; Desai NR; Ahmad T
    Circ Heart Fail; 2019 Nov; 12(11):e006369. PubMed ID: 31707800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Durable ventricular assist device in Spain (2007-2020). First report of the REGALAD registry.
    Gómez-Bueno M; Pérez de la Sota E; Forteza Gil A; Ortiz-Berbel D; Castrodeza J; García-Cosío Carmena MD; Barge-Caballero E; Rangel Sousa D; Díaz Molina B; Manrique Antón R; Almenar-Bonet L; Uribarri González A; Barrio-Rodríguez A; Castel Lavilla MÁ; López-López L; Dobarro Pérez D; Pastor Pérez F; Burgos-Palacios V; Álvarez-García J; Garrido-Jiménez JM; González-Fernández Ó; Codina P; López-Granados A; Grau-Sepulveda A; González-Costello J
    Rev Esp Cardiol (Engl Ed); 2023 Apr; 76(4):227-237. PubMed ID: 36055642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. To ventricular assist devices or not: When is implantation of a ventricular assist device appropriate in advanced ambulatory heart failure?
    Cerier E; Lampert BC; Kilic A; McDavid A; Deo SV; Kilic A
    World J Cardiol; 2016 Dec; 8(12):695-702. PubMed ID: 28070237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural history and clinical effect of aortic valve regurgitation after left ventricular assist device implantation.
    Rajagopal K; Daneshmand MA; Patel CB; Ganapathi AM; Schechter MA; Rogers JG; Milano CA
    J Thorac Cardiovasc Surg; 2013 May; 145(5):1373-9. PubMed ID: 23312101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.